“…Above, we listed some of the L -nucleoside analogues with a solid demonstration of their therapeutic activities, which are summarized in Table 1 . Besides, there are many other nucleoside-like small molecules designed and evaluated as antiviral therapeutics, which had an L -configuration similar to its modified nucleoside, including cyclobutene L -nucleoside analogues [ 72 ], L -erythro-hexopyranosyl nucleosides [ 73 , 74 ], L -4′-C-ethynyl-2′-deoxypurine nucleosides [ 75 ], L -ribo-configured Locked Nucleic Acid [ 76 , 77 , 78 , 79 ], pyrrolo, pyrazolo, or imidazo-modified L -nucleoside [ 80 ], et al There have also been many methods developed to efficiently synthesize carbocyclic L -nucleoside analogues [ 52 , 81 , 82 , 83 ], and they have been summarized elsewhere [ 84 , 85 ].…”